U.S. Healthcare Services Stock News

If you’re eyeing Ameresco’s stock, you’re definitely not alone, and the past month has been anything but boring. After months of flying under the radar, Ameresco has suddenly caught the market’s attention, with its shares surging nearly 50% in just the last 30 days. That kind of move is hard to ignore. Whether this is a turning point or just a temporary boost is the big question facing investors right now. Look a little further back, and you’ll see a see-saw ride: while Ameresco bounced back...

Thinking about what to do with Fair Isaac stock right now? You are not alone. This company is no stranger to dramatic market moves, and recent weeks have shown just how quickly sentiment can turn. In the past week alone, Fair Isaac’s share price climbed an eye-catching 25.6%, capping off a 22.7% gain for the last month. That’s especially striking given the stock is still down a bit for the year, but much higher over the last few years, with an increase of 363.3% over three years and 327.0%...

Recently, Aflac introduced a temporary premium payment grace period for federal government employees impacted by the U.S. government shutdown, allowing eligible policyholders to delay payments until their pay resumes. This operational move highlights Aflac’s approach to customer support and risk management during periods of macroeconomic uncertainty affecting its client base. We'll explore how Aflac's response to the government shutdown affects its investment case and approach to earnings...

In recent news, Piper Sandler analyst Frank Williams initiated coverage on Community Trust Bancorp with a buy rating, coinciding with the company's announcement of a quarterly dividend increase and continued institutional interest. A unique highlight is the company's remarkable record of 44 consecutive years of dividend growth, reinforcing its appeal to income-focused investors. We’ll explore how the dividend increase underscores Community Trust Bancorp’s long-term commitment to shareholder...

Healthpeak Properties (DOC) shares have been moving quietly lately, with performance over the past month showing a slight gain near 4%. Investors may be watching underlying trends as the real estate sector navigates an uncertain market backdrop. See our latest analysis for Healthpeak Properties. While Healthpeak Properties' share price has edged up about 4% over the last month, momentum has not yet reversed a more challenging backdrop. The 1-year total shareholder return remains negative at...

In the past week, Middle Coast Investing highlighted TFS Financial Corporation (NASDAQ:TFSL) in its third-quarter 2025 investor letter, citing its 8%+ dividend and the benefits of recent interest rate cuts. The letter positioned TFS Financial as a compelling bond replacement for investors seeking income, particularly as the company is thought to benefit from a lower interest rate environment. We'll explore how TFS Financial's strong dividend and exposure to interest rate trends could...

In early October 2025, analysts upgraded Seagate Technology Holdings amid increasing institutional interest and higher earnings forecasts, fueled by its HAMR technology advancements targeting AI and cloud storage demands. This momentum is complemented by expectations of renewed share repurchases and rising analyst confidence, highlighting Seagate’s shareholder return potential in the evolving enterprise storage landscape. We’ll explore how Seagate’s analyst upgrades and HAMR technology...

In its third-quarter 2025 investor letter, Middle Coast Investing highlighted Everus Construction Group, Inc. (NYSE:ECG) as benefiting from the data center boom fueled by AI and noted strong year-to-date performance including a 31% increase in second-quarter net sales from the previous year. The investor letter also pointed out that Everus Construction Group’s guidance for the second half appeared improbably low despite sector tailwinds, drawing attention to the company’s potential upside in...

In early October 2025, Airship AI Holdings announced it was awarded 16 contracts totaling US$11.0 million from the US Department of Justice and Department of Homeland Security to provide AI-driven surveillance solutions for public safety and investigations. The selection of Airship AI's Outpost AI platform, following successful pilot deployments that replaced prior systems, highlights increasing federal confidence in the company's proprietary threat detection technology. We'll examine how...

Box (NYSE:BOX) landed a fresh win as FLYING WHALES, a government-backed aerospace company, announced it will broaden its use of Box’s platform to tackle advanced data, compliance, and security demands. See our latest analysis for Box. That high-profile win with FLYING WHALES comes at a time when Box is aiming to strengthen its foothold in heavily regulated and innovation-driven sectors. The share price has edged up 4.6% so far in 2025, and while the 1-year total shareholder return stands at...

In late September 2025, The J. M. Smucker Company announced the launch of two new higher-protein Uncrustables sandwiches, Bright-Eyed Berry and Up & Apple, designed for convenience and balanced nutrition, featuring 12 grams of protein each and aimed at busy consumers seeking functional, on-the-go options. Alongside these product innovations, the company raised its free cash flow outlook for fiscal 2026, reflecting stronger operating confidence and a commitment to debt reduction and financial...

Shares of DXP Enterprises (DXPE) have drawn attention recently given the company's mix of strong year and 3-year returns, even after modest pullbacks over the past month. Investors are weighing what the numbers might suggest for the stock’s value in the future. See our latest analysis for DXP Enterprises. Despite a brief pullback in recent weeks, DXP Enterprises has maintained impressive momentum. The share price is up 41% year-to-date, with a striking 126% total shareholder return over the...

In recent days, LivaNova presented five-year results from its THN-3 randomized control trial and 12-month top-line data from the OSPREY follow-on study for the aura6000™ System at the International Surgical Sleep Society Annual Meeting, highlighting meaningful responder rates in treating moderate to severe obstructive sleep apnea. This scientific data release, paired with additional updates on clinical trial milestones and broader product innovation, has reinvigorated investor interest and...

Ocean Power Technologies recently entered into a securities purchase agreement with institutional investors to issue and sell up to US$25 million in convertible notes, having issued US$16.5 million by October 7, 2025. This transaction injects meaningful new capital into the company, altering its financial structure and signaling management's approach to funding ongoing operations. We will explore how this convertible note financing affects Ocean Power Technologies' investment narrative, with...

On September 26, 2025, LCI Industries and its subsidiaries signed an amendment with JPMorgan Chase Bank to refinance US$399 million in term loans, reducing the interest rates by 0.25% and leaving revolving credit terms unchanged. This refinancing could decrease the company's debt servicing costs, potentially improving financial flexibility and enhancing balance sheet strength. We'll assess how the lowered interest burden from this refinancing may influence LCI Industries' longer-term...

3D Systems recently introduced the MJP 300W Plus, its most advanced 3D wax printer for jewelry manufacturing, featuring three print modes optimized for productivity, material savings, and surface quality improvements through the proprietary Surface Enhance™ feature. This launch responds directly to jeweler needs for manufacturing flexibility and efficiency, with early customer feedback indicating strong market relevance and positive initial adoption. We'll take a closer look at how the MJP...

RBC Capital recently upgraded Crown Castle, as the company announced plans to divest its fiber business and operate exclusively as a tower operator following the completion of the transaction expected in 2026. This move marks a significant shift in Crown Castle’s business model, signaling renewed focus on core tower operations and a potential transformation for its future operating structure. We’ll examine how the planned divestiture of the fiber segment could reshape Crown Castle’s...

Are you wondering whether to stick with your MetLife shares, make your first buy, or take some well-earned profits? You are not alone. MetLife’s stock has seen a quiet yet steady climb, prompting both seasoned investors and newcomers to consider its next moves. Over the past week, shares in MetLife nudged up by 0.5%, but that is just a slice of a much bigger story; in the last five years, the stock is up nearly 149%. This long-term momentum suggests more than just short-term sentiment...

Onto Innovation (ONTO) has drawn investor attention lately thanks to steady growth trends across its annual results. Over the past month, shares have gained nearly 30%, which highlights renewed confidence in the company’s direction. See our latest analysis for Onto Innovation. After a tough start to the year, Onto Innovation’s momentum has picked up dramatically, with a 29.8% one-month share price return driving renewed optimism despite a 35.3% decline in total shareholder return over the...

Coursera announced it is one of OpenAI’s first generation of apps in ChatGPT, marking the first time an online learning platform has been embedded directly within ChatGPT conversations for hundreds of millions of users. This integration allows ChatGPT users to seamlessly access Coursera’s educational videos and content, significantly enhancing the discoverability and accessibility of world-class educational resources. We’ll now review how embedding Coursera’s content in ChatGPT could...

Carter’s, Inc. (NYSE:CRI) recently reported a 4% increase in net sales for fiscal Q2 2025 compared to the previous year period. Despite the sales growth, analyst reactions following the earnings release highlighted caution as they maintained reserved outlooks on the stock’s future performance. Now, we'll explore how analysts' reserved outlooks following Carter's earnings update may impact its broader investment narrative. AI is about to change healthcare. These 32 stocks are working on...

Wondering what to do with Viatris stock? You are definitely not alone. Lately, this pharmaceutical giant has given investors plenty to think about, and the conversation around its value just keeps picking up steam. Over the past week, Viatris shares moved up 2.4%, offering a glimmer of momentum after drifting lower in the previous months. But zooming out, performance has been a mixed bag: the stock is down 18.4% year-to-date and 6.1% over the last year, while still holding onto a 23.8% gain...

Shares of Tarsus Pharmaceuticals recently surged after strong investor optimism was sparked by robust demand for Xdemvy, its prescription eye drop for Demodex blepharitis. The momentum is further fueled by anticipation for mid-stage clinical trials for additional indications, highlighting Tarsus’s efforts to diversify its pipeline beyond its lead product. We'll now explore how Xdemvy's rapid uptake and expanding clinical programs shape the evolving investment narrative for Tarsus...

Biomea Fusion, Inc. recently announced positive 52-week results from its Phase II COVALENT-111 study of icovamenib in type 2 diabetes, reporting statistically significant and clinically meaningful reductions in HbA1c, especially for patients with severe insulin-deficient diabetes and those not reaching glycemic targets on GLP-1 therapy. The favorable safety profile and planned next steps, including additional trials and ongoing studies, highlight the company’s continued progress in...